IL6R and immune system disorder: Therefore, MTX could better neutralize activated and proliferating CD73+ Teff, while anti-IL-6R might target CD73neg Teff; their combined action provide a better regulation of the overall hyper activated Teff population in the contexts of auto-immune disorders.